American Shared Hospital Services (NYSE American: AMS), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, today announced that it will hold a conference call to discuss its fourth quarter and full year 2025 financial results on March 31st at 12:00 pm ET. The financial results press release will be issued before the market opens on the same day.
The call will be accessible to domestic participants by dialing 1-844-413-3972 and international participants by dialing 1-412-317-5776 at least ten minutes prior to the start time. Participants should ask to join the American Shared Hospital Services call. A simultaneous webcast will be available through the Company's website at www.ashs.com or directly at https://event.choruscall.com/mediaframe/webcast.html?webcastid=QqZruHXQ. A replay of the call will be available by dialing 1-855-669-9658 or 1-412-317-0088, access code 6331493, through April 7, 2026, and will also be archived on the Company's website.
American Shared Hospital Services operates through two segments: equipment leasing and direct patient care services. The company provides turnkey solutions to cancer treatment centers, health systems, and cancer networks across North and South America. Its offerings include Gamma Knife, proton therapy, and advanced radiation therapy systems. Under health system partnerships, the Company and its partners share capital investment costs and profitability based on ownership interests.
The upcoming conference call is significant for investors and industry observers as it will provide detailed financial performance metrics for the fourth quarter and full year 2025, offering insights into the company's revenue trends, operational efficiency, and strategic initiatives. Given the company's focus on expanding its cancer treatment services, the call may also address growth prospects, market conditions, and the impact of reimbursement policies on its business model.
In its safe harbor statement, the Company cautions that forward-looking statements involve risks and uncertainties, including economic conditions, variability of financial results, changes in CMS reimbursement rates, and the timing and financing of new projects. These factors could cause actual results to differ materially from expectations. For more information, investors are encouraged to review the Company's filings with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q and Annual Report on Form 10-K.
The financial results and management commentary during the call will be crucial for stakeholders to assess the company's performance in a competitive landscape and its ability to sustain growth amidst industry challenges.
